Suppr超能文献

寻找克服癌症化疗耐药性的新途径:干细胞来源的外泌体 microRNAs 的作用。

Find new channel for overcoming chemoresistance in cancers: Role of stem cells-derived exosomal microRNAs.

机构信息

Department of Pharmacy, Al-Mustaqbal University College, Babylon, Hilla 51001, Iraq.

Department of Dentistry, Al-Mustaqbal University College, Babylon, Hilla 51001, Iraq.

出版信息

Int J Biol Macromol. 2022 Oct 31;219:530-537. doi: 10.1016/j.ijbiomac.2022.07.253. Epub 2022 Aug 7.

Abstract

Chemoresistance has remained a significant concern in tumor recurrence and elevated cancer-related mortalities. A deep insight into mechanisms by which cancerous cells resist administered drugs can pave the way to overcome chemotherapy-induced cell death and develop novel procedures to rescue patients. Regarding accumulated data, stem cell-derived exosomal microRNAs (miRNAs) can be deemed a novel and promising method to overcome chemoresistance. It seems exosomal miRNAs play a dual role in the cancer microenvironment. On the one hand, as a messenger, they are transferred between donor and recipient cells contributing to cancer chemoresistance. On the other hand, stem cell-derived exosomal miRNA significantly restrains tumorigenesis and inhibits or alleviates drug resistance in the tumor niche. Hence, our purpose in this review evaluating the roles of stem cells-derived exosomal microRNAs in overcoming chemoresistance in tumors.

摘要

耐药性仍然是肿瘤复发和癌症相关死亡率升高的一个重大问题。深入了解癌细胞抵抗给药药物的机制可以为克服化疗诱导的细胞死亡和开发新的程序来拯救患者铺平道路。关于已积累的数据,源自干细胞的细胞外体 microRNAs(miRNAs)可以被视为克服耐药性的一种新颖且有前途的方法。似乎源自干细胞的细胞外体 miRNAs 在癌症微环境中发挥双重作用。一方面,作为信使,它们在供体细胞和受体细胞之间传递,有助于癌症耐药性。另一方面,源自干细胞的细胞外体 miRNA 可显著抑制肿瘤发生,并抑制或减轻肿瘤微环境中的耐药性。因此,我们在本次综述中的目的是评估源自干细胞的细胞外体 microRNAs 在克服肿瘤耐药性中的作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验